STI571: An inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia

Michael E. O'Dwyer, Brian J. Druker

Research output: Contribution to journalReview articlepeer-review

57 Scopus citations

Fingerprint

Dive into the research topics of 'STI571: An inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia'. Together they form a unique fingerprint.

Medicine & Life Sciences